Certara appoints john reynders as new independent board member

Radnor, pa., oct. 16, 2024 (globe newswire) -- certara, inc. (nasdaq: cert), a global leader in model-informed drug development, today announced the appointment of john reynders, phd, to its board of directors, effective october 15, 2024.

CERT Ratings Summary

CERT Quant Ranking